VMD Viemed Healthcare Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: VMD

Price (delayed)

$8.8

Market cap

$335.18M

P/E Ratio

23.78

Dividend/share

N/A

EPS

$0.37

Enterprise value

$336.1M

?
Relative Growth: Rel. Growth: 81
Relative Strength: Rel. Strength: 50
Relative Valuation: Rel. Valuation: 70
Relative Profitability: Rel. Profitability: 64

Viemed, through its indirect wholly-owned subsidiaries Sleep Management, L.L.C. and Home Sleep Delivered, L.L.C., is a home medical equipment supplier that provides post-acute respiratory care services in the United States. ...

Highlights
The company's debt fell by 27% YoY and by 7% QoQ
The revenue has grown by 25% year-on-year and by 5% since the previous quarter
The price to earnings (P/E) is 19% lower than the 5-year quarterly average of 29.8 but 3.1% higher than the last 4 quarters average of 23.5
The net income has increased by 3.7% year-on-year but it has declined by 2.6% since the previous quarter
VMD's quick ratio is down by 11% since the previous quarter and by 5% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://www.viemed.com
Peers: OPCH PNTG

Key stats

What are the main financial stats of VMD

VMD stock price

How has the Viemed Healthcare stock price performed over time
Intraday
-1.79%
1 week
-1.57%
1 month
-0.56%
1 year
30.37%
YTD
18.44%
QTD
-22.81%

Financial performance

How have Viemed Healthcare's revenue and profit performed over time
Revenue
$301.61M
Gross profit
$173.32M
Operating income
$22.77M
Net income
$14.5M
Gross margin
57.5%
Net margin
4.8%
The revenue has grown by 25% year-on-year and by 5% since the previous quarter
VMD's gross profit is up by 23% YoY and by 5% QoQ
The company's net margin fell by 17% YoY and by 8% QoQ
The operating margin is down by 14% year-on-year and by 9% since the previous quarter

Price vs fundamentals

How does VMD's price correlate with its fundamentals

Growth

What is Viemed Healthcare's growth rate over time

Valuation

What is Viemed Healthcare stock price valuation
VMD P/E details
P/E
23.78
P/B
2.34
P/S
1.12
EV/EBIT
15.22
EV/EBITDA
6.42
EV/Sales
1.11
The price to earnings (P/E) is 19% lower than the 5-year quarterly average of 29.8 but 3.1% higher than the last 4 quarters average of 23.5
Viemed Healthcare's EPS has increased by 2.8% YoY but it has decreased by 2.6% QoQ
The P/S is 29% below the 5-year quarterly average of 1.6 and 5% below the last 4 quarters average of 1.2
The revenue has grown by 25% year-on-year and by 5% since the previous quarter

Efficiency

How efficient is Viemed Healthcare business performance
Viemed Healthcare's return on sales has decreased by 15% YoY and by 9% QoQ
The ROA is down by 4% QoQ and by 2.7% YoY
The company's return on invested capital fell by 3.1% QoQ
The ROE has contracted by 2.8% from the previous quarter

Dividends

What is VMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VMD.

Financial health

How did Viemed Healthcare financials performed over time
The total liabilities is up by 13% since the previous quarter and by 4.7% year-on-year
VMD's quick ratio is down by 11% since the previous quarter and by 5% year-on-year
The company's debt is 92% lower than its equity
The company's debt fell by 27% YoY and by 7% QoQ
Viemed Healthcare's debt to equity has decreased by 27% YoY and by 11% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.